302 related articles for article (PubMed ID: 27288631)
21. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
Ito S; Yukawa T; Uetake S; Yamauchi M
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
[TBL] [Abstract][Full Text] [Related]
22. Chemokine (C-X-C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt.
Berres ML; Lehmann J; Jansen C; Görtzen J; Meyer C; Thomas D; Zimmermann HW; Kroy D; Schumacher F; Strassburg CP; Sauerbruch T; Trautwein C; Wasmuth HE; Trebicka J
Liver Int; 2016 Mar; 36(3):386-94. PubMed ID: 26212075
[TBL] [Abstract][Full Text] [Related]
23. Circulating levels of butyrate are inversely related to portal hypertension, endotoxemia, and systemic inflammation in patients with cirrhosis.
Juanola O; Ferrusquía-Acosta J; García-Villalba R; Zapater P; Magaz M; Marín A; Olivas P; Baiges A; Bellot P; Turon F; Hernández-Gea V; González-Navajas JM; Tomás-Barberán FA; García-Pagán JC; Francés R
FASEB J; 2019 Oct; 33(10):11595-11605. PubMed ID: 31345057
[TBL] [Abstract][Full Text] [Related]
24. Hepatic lipocalin 2 promotes liver fibrosis and portal hypertension.
Chen J; Argemi J; Odena G; Xu MJ; Cai Y; Massey V; Parrish A; Vadigepalli R; Altamirano J; Cabezas J; Gines P; Caballeria J; Snider N; Sancho-Bru P; Akira S; Rusyn I; Gao B; Bataller R
Sci Rep; 2020 Sep; 10(1):15558. PubMed ID: 32968110
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and indicators of portal hypertension in patients with nonalcoholic fatty liver disease.
Mendes FD; Suzuki A; Sanderson SO; Lindor KD; Angulo P
Clin Gastroenterol Hepatol; 2012 Sep; 10(9):1028-33.e2. PubMed ID: 22610002
[TBL] [Abstract][Full Text] [Related]
26. Serum lipocalin-2, cathepsin S and chemerin levels and nonalcoholic fatty liver disease.
Ye Z; Wang S; Yang Z; He M; Zhang S; Zhang W; Wen J; Li Q; Huang Y; Wang X; Lu B; Zhang Z; Su Q; Hu R
Mol Biol Rep; 2014 Mar; 41(3):1317-23. PubMed ID: 24390241
[TBL] [Abstract][Full Text] [Related]
27. Circulating Elastin Fragments Are Not Affected by Hepatic, Renal and Hemodynamic Changes, But Reflect Survival in Cirrhosis with TIPS.
Nielsen MJ; Lehmann J; Leeming DJ; Schierwagen R; Klein S; Jansen C; Strassburg CP; Bendtsen F; Møller S; Sauerbruch T; Karsdal MA; Krag A; Trebicka J
Dig Dis Sci; 2015 Nov; 60(11):3456-64. PubMed ID: 26138655
[TBL] [Abstract][Full Text] [Related]
28. Establishment of a hepatic cirrhosis and portal hypertension model by hepatic arterial perfusion with 80% alcohol.
Wang L; He FL; Liu FQ; Yue ZD; Zhao HW
World J Gastroenterol; 2015 Aug; 21(32):9544-53. PubMed ID: 26327762
[TBL] [Abstract][Full Text] [Related]
29. Associations of systemic sphingolipids with measures of hepatic function in liver cirrhosis are related to cholesterol.
Krautbauer S; Wiest R; Liebisch G; Buechler C
Prostaglandins Other Lipid Mediat; 2017 Jul; 131():25-32. PubMed ID: 28647317
[TBL] [Abstract][Full Text] [Related]
30. Adipokines in Liver Cirrhosis.
Buechler C; Haberl EM; Rein-Fischboeck L; Aslanidis C
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28661458
[TBL] [Abstract][Full Text] [Related]
31. Low circulating chemerin levels correlate with hepatic dysfunction and increased mortality in decompensated liver cirrhosis.
Horn P; von Loeffelholz C; Forkert F; Stengel S; Reuken P; Aschenbach R; Stallmach A; Bruns T
Sci Rep; 2018 Jun; 8(1):9242. PubMed ID: 29915268
[TBL] [Abstract][Full Text] [Related]
32. Noninvasive assessment of liver steatosis, fibrosis and inflammation in chronic hepatitis C virus infection.
Schneider AR; Teuber G; Kriener S; Caspary WF
Liver Int; 2005 Dec; 25(6):1150-5. PubMed ID: 16343065
[TBL] [Abstract][Full Text] [Related]
33. A Scoping Review on Lipocalin-2 and Its Role in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma.
Krizanac M; Mass Sanchez PB; Weiskirchen R; Asimakopoulos A
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799862
[TBL] [Abstract][Full Text] [Related]
34. Procoagulant imbalance in patients with non-alcoholic fatty liver disease.
Tripodi A; Fracanzani AL; Primignani M; Chantarangkul V; Clerici M; Mannucci PM; Peyvandi F; Bertelli C; Valenti L; Fargion S
J Hepatol; 2014 Jul; 61(1):148-54. PubMed ID: 24657400
[TBL] [Abstract][Full Text] [Related]
35. Serum levels of bone sialoprotein correlate with portal pressure in patients with liver cirrhosis.
Benz F; Bogen A; Praktiknjo M; Jansen C; Meyer C; Wree A; Demir M; Loosen S; Vucur M; Schierwagen R; Tacke F; Trebicka J; Roderburg C
PLoS One; 2020; 15(4):e0231701. PubMed ID: 32302330
[TBL] [Abstract][Full Text] [Related]
36. Different hemodynamic patterns of alcoholic and viral endstage cirrhosis: analysis of explanted liver weight, degree of fibrosis and splanchnic Doppler parameters.
Bolognesi M; Sacerdoti D; Mescoli C; Bombonato G; Cillo U; Merenda R; Giacomelli L; Merkel C; Rugge M; Gatta A
Scand J Gastroenterol; 2007 Feb; 42(2):256-62. PubMed ID: 17327946
[TBL] [Abstract][Full Text] [Related]
37. Peripheral and Hepatic Vein Cytokine Levels in Correlation with Non-Alcoholic Fatty Liver Disease (NAFLD)-Related Metabolic, Histological, and Haemodynamic Features.
Vonghia L; Magrone T; Verrijken A; Michielsen P; Van Gaal L; Jirillo E; Francque S
PLoS One; 2015; 10(11):e0143380. PubMed ID: 26599575
[TBL] [Abstract][Full Text] [Related]
38. [Clinical study of non-alcoholic fatty liver disease and its combined the chronic HBV infection].
He J; Zeng YL; Li W; Guo EE; Li JL; Kang Y; Shang J
Zhonghua Gan Zang Bing Za Zhi; 2017 Aug; 25(8):618-622. PubMed ID: 29056013
[No Abstract] [Full Text] [Related]
39. Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.
Lemoine M; Ratziu V; Kim M; Maachi M; Wendum D; Paye F; Bastard JP; Poupon R; Housset C; Capeau J; Serfaty L
Liver Int; 2009 Oct; 29(9):1431-8. PubMed ID: 19422483
[TBL] [Abstract][Full Text] [Related]
40. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis.
Lemoine M; Katsahian S; Ziol M; Nahon P; Ganne-Carrie N; Kazemi F; Grando-Lemaire V; Trinchet JC; Beaugrand M
Aliment Pharmacol Ther; 2008 Nov; 28(9):1102-10. PubMed ID: 18691352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
